Galenica S and Etienne Jornod

Etienne Jornod: Reuters Shares in Swiss pharmacies operator and drugs firm Galenica S jumped on Tuesday after the company said it planned to list its two main arms separately as soon as 2017, fuelling speculation that the drug unit could be picked up in a takeover, according to Euro News. Galenicas chairman, Etienne Jornod, has long resisted calls from analysts and investors to split up the company, in which he is also a major shareholder. As recently as when it held an investor day in June Galenica has denied that the company would change its current structure and By Katharina Bart and Oliver Hirt Large drugmakers have undertaken more than $100 billion 79.47 billion pound worth of acquisitions in the first six months this year, according to ratings agency Moodys, as companies look to build scale in leading businesses or acquire a foreign tax domicile to cut their tax bills, a tactic known as inversion. (news.financializer.com). As reported in the news.